Chanice Knight
DPhil student
In 2019 Chanice graduated a Masters of Research degree at the University of Bristol focusing on innate and adaptive immune responses to H1N1 influenza A virus. After this she worked as a research scientist at the University of Bristol focusing on CD8+ T cells and interferon stimulating genes. Drawing on her interests in clinical research, Chanice accepted a position as a Scientist at the UK Health Security Agency, where she worked as part of the Vaccine Task Force. Chanice has been working on SARS-CoV-2 neutralising antibody responses since 2020, a topic which she has continued at the Nuffield Department of Medicine in the Simmonds Group. Her interests and expertise are immunofluorescent histology, confocal microscopy, live virus neutralisation assays, ACDP Containment level 3 trainer, virology and immunology.
Recent publications
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.
Journal article
Strain R. et al, (2025), Hepatology
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial.
Journal article
Nurmi V. et al, (2025), J Infect, 90
The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors.
Journal article
Nurmi V. et al, (2023), J Infect Dis, 228, 245 - 250
Absence of detectable monkeypox virus DNA in 11,000 English blood donations during the 2022 outbreak.
Journal article
Knight C. et al, (2023), Transfusion, 63, 690 - 695